• Profile
Dr. Jothydev Kesavadev
Unmute Video
Dr. Jothydev Kesavadev discusses the limit... more»Dr. Jothydev Kesavadev discusses the limitations of HbA1c and its current irrelevancy in diabetes management. He also throws light on the new time- in range metric, a more effective, ADA-recommended measure that can enable effective glucose control. «less

By Jothydev Kesavadev | Jul 22, 2021

This Sunday, we bring to you an article fr... more»This Sunday, we bring to you an article from our archives. Dr. Jothydev Kesavadev writes on glucose monitoring in diabetes and the significance of time-in-range as a new metric for better glycaemic control in patients with diabetes. «less
Aug 23, 2020
Dr. Jothydev Kesavadev writes on continuou... more»Dr. Jothydev Kesavadev writes on continuous glucose monitoring (CGM) system which has in recent times, become an important part of disease management in diabetes patients. In this article, he focuses on classification of CGM with merits and demerits of the system. «less
Feb 10, 2020
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen